Pink004的个人主页 - 老虎社区

Pink004

Pink004

暂无个人介绍

IP属地：未知

173关注

4粉丝

0主题

0勋章

2021-07-30

Good

抱歉，原内容已删除

2021-07-16

Good

抱歉，原内容已删除

2021-07-15

Good

Here's Why Apple Stock Jumped to a New All-Time High Wednesday<blockquote>这就是苹果股价周三跃升至历史新高的原因</blockquote>

2021-07-13

good//@螞蟻東尼:這篇文章不錯，轉發給大家看看

@阳光财经: 美股分析：重大节日，纳指奔向16000点。重大节日再次创出历史新高，只要拿稳前5大科技股，就没有不赚钱的。今天的视频我们会分析，为什么纳指有希望奔向16000点，然后PK一下$苹果(AAPL)$ 和$微软(MSFT)$ ，两大股王，谁更值得买入。我已经买了其中一只，现在觉得稳稳的。

2021-07-08

👍

U.S. FDA narrows patient group for Biogen's Alzheimer's drug<blockquote>美国FDA缩小百健阿尔茨海默病药物患者群体范围</blockquote>

2021-07-06

No

抱歉，原内容已删除

2021-07-06

No.no.no

抱歉，原内容已删除

2021-07-03

Good

抱歉，原内容已删除

2021-06-26

Good

抱歉，原内容已删除

2021-06-15

Agreed 👍

抱歉，原内容已删除

2021-06-13

Good//@螞蟻東尼: 這篇文章不錯，轉發給大家看看

@阳光财经: 美股分析：这么一大利空，标普创新高无果。

2021-06-13

Good

抱歉，原内容已删除

2021-06-12

Good

抱歉，原内容已删除

2021-06-10

Haiz

抱歉，原内容已删除

2021-06-09

It Is game over

抱歉，原内容已删除

2021-06-04

Unbelievable

抱歉，原内容已删除

2021-06-03

Good

抱歉，原内容已删除

2021-06-03

Good

抱歉，原内容已删除

2021-06-02

Good

抱歉，原内容已删除

2021-06-01

Good move

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3577341055310022","uuid":"3577341055310022","gmtCreate":1614421827085,"gmtModify":1621389672847,"name":"Pink004","pinyin":"pink004","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":4,"headSize":173,"tweetSize":30,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.04.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"wearingSort":0},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.65%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"wearingSort":0},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.99%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"wearingSort":0}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":808626694,"gmtCreate":1627575067718,"gmtModify":1631884986818,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577341055310022","authorIdStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/808626694","repostId":"1165345369","repostType":4,"isVote":1,"tweetType":1,"viewCount":3021,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":170737981,"gmtCreate":1626450507243,"gmtModify":1631884986830,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577341055310022","authorIdStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/170737981","repostId":"1179740731","repostType":4,"isVote":1,"tweetType":1,"viewCount":2396,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":144576348,"gmtCreate":1626308171784,"gmtModify":1631884986841,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577341055310022","authorIdStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/144576348","repostId":"1158174802","repostType":4,"repost":{"id":"1158174802","kind":"news","pubTimestamp":1626307894,"share":"https://www.laohu8.com/m/news/1158174802?lang=zh_CN&edition=full","pubTime":"2021-07-15 08:11","market":"us","language":"en","title":"Here's Why Apple Stock Jumped to a New All-Time High Wednesday<blockquote>这就是苹果股价周三跃升至历史新高的原因</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1158174802","media":"Motley Fool","summary":"Shareholders could be in store for even more gains.Shares of $Apple$ climbed to a record high on Wednesday, following bullish analyst commentary and reports of substantially higher iPhone production rates. As of 2 p.m. EDT, the stock's price was up more than 2%, which placed Apple's market capitalization at a staggering $2.5 trillion.Apple is expected to debut its latest-generation iPhones in September. Upgraded processors, displays, and cameras should all help to add to the device's allure amon","content":"<p>  Shareholders could be in store for even more gains.  <img src=\"https://static.tigerbbs.com/1ccdffb5c79b7b06da6ba63aa32eabb0\" tg-width=\"663\" tg-height=\"440\" referrerpolicy=\"no-referrer\"></p><p><blockquote>股东可能会获得更多收益。</blockquote></p><p> <b>What happened</b></p><p><blockquote><b>发生了什么</b></blockquote></p><p> Shares of&nbsp;<b><a href=\"https://laohu8.com/S/AAPL\">Apple</a></b>&nbsp;climbed to a record high on Wednesday, following bullish analyst commentary and reports of substantially higher iPhone production rates. As of 2 p.m. EDT, the stock's price was up more than 2%, which placed Apple's market capitalization at a staggering $2.5 trillion.</p><p><blockquote>本公司之股份<b><a href=\"https://laohu8.com/S/AAPL\">苹果</a></b>在分析师发表看涨评论和iPhone生产率大幅提高的报道后，周三攀升至历史新高。截至下午2点美国东部时间，该股股价上涨超过2%，使苹果的市值达到惊人的2.5万亿美元。</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> Thetechtitan is striving to manufacture as many as 90 million of its newest iPhones this year, according to Bloomberg. Apple is reportedly preparing to boost shipments by 20% compared to 2020's levels.</p><p><blockquote>据彭博社报道，这家科技巨头今年力争生产多达9000万部最新iPhone。据报道，苹果正准备将出货量比2020年的水平提高20%。</blockquote></p><p> Apple is expected to debut its latest-generation iPhones in September. Upgraded processors, displays, and cameras should all help to add to the device's allure among consumers.</p><p><blockquote>苹果预计将于9月推出最新一代iPhone。升级的处理器、显示屏和摄像头都应该有助于增加该设备在消费者中的吸引力。</blockquote></p><p> Meanwhile, analyst Samik Chatterjee added Apple to J.P. Morgan's \"focus list\" on Wednesday. Chatterjee sees Apple's shares reaching $175, fueled by higher iPhone and Mac sales. If he's correct, shareholders could enjoy gains of roughly 17% from the stock's current price near $149.</p><p><blockquote>与此同时，分析师Samik Chatterjee周三将苹果列入摩根大通的“关注名单”。Chatterjee预计，在iPhone和Mac销量增加的推动下，苹果股价将达到175美元。如果他是正确的，股东可以从目前接近149美元的股价中获得约17%的收益。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在怎么办</b></blockquote></p><p> Apple is in the midst of a 5G-fueled iPhone supercycle. The fifth-generation wireless technology promises to provide users with blazingly fast download speeds and enable a host of advanced technologies.</p><p><blockquote>苹果正处于5G推动的iPhone超级周期之中。第五代无线技术有望为用户提供极快的下载速度，并支持一系列先进技术。</blockquote></p><p> Surging iPhone sales are also boosting demand for Apple's steadily expanding array of services. These high-margin revenue streams, in turn, are helping to fuel the company's stunning earnings growth. <a href=\"https://laohu8.com/S/ISBC\">Investors</a> -- excited about the prospect of even greater profits ahead -- are bidding up the tech giant's shares to new all-time highs Wednesday.</p><p><blockquote>iPhone销量的飙升也提振了对苹果稳步扩大的服务系列的需求。这些高利润收入来源反过来又有助于推动公司惊人的盈利增长。<a href=\"https://laohu8.com/S/ISBC\">投资者</a>——对未来更大利润的前景感到兴奋——周三将这家科技巨头的股价推高至历史新高。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's Why Apple Stock Jumped to a New All-Time High Wednesday<blockquote>这就是苹果股价周三跃升至历史新高的原因</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's Why Apple Stock Jumped to a New All-Time High Wednesday<blockquote>这就是苹果股价周三跃升至历史新高的原因</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-07-15 08:11</span>\n</p>\n</h4>\n</header>\n<article>\n<p>  Shareholders could be in store for even more gains.  <img src=\"https://static.tigerbbs.com/1ccdffb5c79b7b06da6ba63aa32eabb0\" tg-width=\"663\" tg-height=\"440\" referrerpolicy=\"no-referrer\"></p><p><blockquote>股东可能会获得更多收益。</blockquote></p><p> <b>What happened</b></p><p><blockquote><b>发生了什么</b></blockquote></p><p> Shares of&nbsp;<b><a href=\"https://laohu8.com/S/AAPL\">Apple</a></b>&nbsp;climbed to a record high on Wednesday, following bullish analyst commentary and reports of substantially higher iPhone production rates. As of 2 p.m. EDT, the stock's price was up more than 2%, which placed Apple's market capitalization at a staggering $2.5 trillion.</p><p><blockquote>本公司之股份<b><a href=\"https://laohu8.com/S/AAPL\">苹果</a></b>在分析师发表看涨评论和iPhone生产率大幅提高的报道后，周三攀升至历史新高。截至下午2点美国东部时间，该股股价上涨超过2%，使苹果的市值达到惊人的2.5万亿美元。</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> Thetechtitan is striving to manufacture as many as 90 million of its newest iPhones this year, according to Bloomberg. Apple is reportedly preparing to boost shipments by 20% compared to 2020's levels.</p><p><blockquote>据彭博社报道，这家科技巨头今年力争生产多达9000万部最新iPhone。据报道，苹果正准备将出货量比2020年的水平提高20%。</blockquote></p><p> Apple is expected to debut its latest-generation iPhones in September. Upgraded processors, displays, and cameras should all help to add to the device's allure among consumers.</p><p><blockquote>苹果预计将于9月推出最新一代iPhone。升级的处理器、显示屏和摄像头都应该有助于增加该设备在消费者中的吸引力。</blockquote></p><p> Meanwhile, analyst Samik Chatterjee added Apple to J.P. Morgan's \"focus list\" on Wednesday. Chatterjee sees Apple's shares reaching $175, fueled by higher iPhone and Mac sales. If he's correct, shareholders could enjoy gains of roughly 17% from the stock's current price near $149.</p><p><blockquote>与此同时，分析师Samik Chatterjee周三将苹果列入摩根大通的“关注名单”。Chatterjee预计，在iPhone和Mac销量增加的推动下，苹果股价将达到175美元。如果他是正确的，股东可以从目前接近149美元的股价中获得约17%的收益。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在怎么办</b></blockquote></p><p> Apple is in the midst of a 5G-fueled iPhone supercycle. The fifth-generation wireless technology promises to provide users with blazingly fast download speeds and enable a host of advanced technologies.</p><p><blockquote>苹果正处于5G推动的iPhone超级周期之中。第五代无线技术有望为用户提供极快的下载速度，并支持一系列先进技术。</blockquote></p><p> Surging iPhone sales are also boosting demand for Apple's steadily expanding array of services. These high-margin revenue streams, in turn, are helping to fuel the company's stunning earnings growth. <a href=\"https://laohu8.com/S/ISBC\">Investors</a> -- excited about the prospect of even greater profits ahead -- are bidding up the tech giant's shares to new all-time highs Wednesday.</p><p><blockquote>iPhone销量的飙升也提振了对苹果稳步扩大的服务系列的需求。这些高利润收入来源反过来又有助于推动公司惊人的盈利增长。<a href=\"https://laohu8.com/S/ISBC\">投资者</a>——对未来更大利润的前景感到兴奋——周三将这家科技巨头的股价推高至历史新高。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/07/14/heres-why-apple-stock-jumped-to-a-new-all-time-hig/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09086":"华夏纳指-U","NGD":"New Gold","AAPL":"苹果","03086":"华夏纳指"},"source_url":"https://www.fool.com/investing/2021/07/14/heres-why-apple-stock-jumped-to-a-new-all-time-hig/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158174802","content_text":"Shareholders could be in store for even more gains.\n\n\nWhat happened\nShares of Apple climbed to a record high on Wednesday, following bullish analyst commentary and reports of substantially higher iPhone production rates. As of 2 p.m. EDT, the stock's price was up more than 2%, which placed Apple's market capitalization at a staggering $2.5 trillion.\nSo what\nThetechtitan is striving to manufacture as many as 90 million of its newest iPhones this year, according to Bloomberg. Apple is reportedly preparing to boost shipments by 20% compared to 2020's levels.\nApple is expected to debut its latest-generation iPhones in September. Upgraded processors, displays, and cameras should all help to add to the device's allure among consumers.\nMeanwhile, analyst Samik Chatterjee added Apple to J.P. Morgan's \"focus list\" on Wednesday. Chatterjee sees Apple's shares reaching $175, fueled by higher iPhone and Mac sales. If he's correct, shareholders could enjoy gains of roughly 17% from the stock's current price near $149.\nNow what\nApple is in the midst of a 5G-fueled iPhone supercycle. The fifth-generation wireless technology promises to provide users with blazingly fast download speeds and enable a host of advanced technologies.\nSurging iPhone sales are also boosting demand for Apple's steadily expanding array of services. These high-margin revenue streams, in turn, are helping to fuel the company's stunning earnings growth. Investors -- excited about the prospect of even greater profits ahead -- are bidding up the tech giant's shares to new all-time highs Wednesday.","news_type":1,"symbols_score_info":{"09086":0.9,"NGD":0.9,"AAPL":0.9,"03086":0.9}},"isVote":1,"tweetType":1,"viewCount":3509,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":145913981,"gmtCreate":1626185818443,"gmtModify":1631884986852,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577341055310022","authorIdStr":"3577341055310022"},"themes":[],"title":"","htmlText":"good//<a href=\"https://laohu8.com/U/3570755698252810\">@螞蟻東尼</a>:這篇文章不錯，轉發給大家看看","listText":"good//<a href=\"https://laohu8.com/U/3570755698252810\">@螞蟻東尼</a>:這篇文章不錯，轉發給大家看看","text":"good//@螞蟻東尼:這篇文章不錯，轉發給大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/145913981","repostId":"155626240","repostType":1,"repost":{"id":155626240,"gmtCreate":1625414672374,"gmtModify":1625585035721,"author":{"id":"3468322318173915","authorId":"3468322318173915","name":"阳光财经","avatar":"https://static.tigerbbs.com/ae4ab676f150a8d357cb5f3e4956d1a0","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3468322318173915","authorIdStr":"3468322318173915"},"themes":[],"title":"","htmlText":"\n \n \n  美股分析：重大节日，纳指奔向16000点。 重大节日再次创出历史新高，只要拿稳前5大科技股，就没有不赚钱的。 今天的视频我们会分析，为什么纳指有希望奔向16000点，然后PK一下$苹果(AAPL)$ 和$微软(MSFT)$ ，两大股王，谁更值得买入。我已经买了其中一只，现在觉得稳稳的。\n \n","listText":"美股分析：重大节日，纳指奔向16000点。 重大节日再次创出历史新高，只要拿稳前5大科技股，就没有不赚钱的。 今天的视频我们会分析，为什么纳指有希望奔向16000点，然后PK一下$苹果(AAPL)$ 和$微软(MSFT)$ ，两大股王，谁更值得买入。我已经买了其中一只，现在觉得稳稳的。","text":"美股分析：重大节日，纳指奔向16000点。 重大节日再次创出历史新高，只要拿稳前5大科技股，就没有不赚钱的。 今天的视频我们会分析，为什么纳指有希望奔向16000点，然后PK一下$苹果(AAPL)$ 和$微软(MSFT)$ ，两大股王，谁更值得买入。我已经买了其中一只，现在觉得稳稳的。","images":[{"img":"https://static.tigerbbs.com/ba1369048ae43f622980bb91c23c7c43","width":"0","height":"0"}],"top":1,"highlighted":2,"essential":2,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/155626240","isVote":1,"tweetType":2,"object":{"id":"db32d9da23344a86826b18e89f2adb7a","tweetId":"155626240","title":"美股分析：重大节日，纳指奔向16000点。","videoUrl":"http://v.tigerbbs.com/16254146691280ea7d902da8ded6f3ddaa98f7f579134.mp4","poster":"https://static.tigerbbs.com/ba1369048ae43f622980bb91c23c7c43","shareLink":"http://v.tigerbbs.com/16254146691280ea7d902da8ded6f3ddaa98f7f579134.mp4"},"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":2018,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":143092981,"gmtCreate":1625751825943,"gmtModify":1631884986868,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577341055310022","authorIdStr":"3577341055310022"},"themes":[],"title":"","htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/143092981","repostId":"1184325113","repostType":4,"repost":{"id":"1184325113","kind":"news","pubTimestamp":1625750497,"share":"https://www.laohu8.com/m/news/1184325113?lang=zh_CN&edition=full","pubTime":"2021-07-08 21:21","market":"us","language":"en","title":"U.S. FDA narrows patient group for Biogen's Alzheimer's drug<blockquote>美国FDA缩小百健阿尔茨海默病药物患者群体范围</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1184325113","media":"Reuters","summary":"July 8 (Reuters) - Biogen Inc said the U.S. drug regulator has narrowed the patient group that can u","content":"<p>July 8 (Reuters) - Biogen Inc said the U.S. drug regulator has narrowed the patient group that can use its Alzheimer’s disease drug, after the agency drew sharp criticism for approving the drug last month without proof of clear benefit against the disease.</p><p><blockquote>路透7月8日-百健公司(Biogen Inc)表示，美国药品监管机构已缩小了可以使用其阿尔茨海默病药物的患者群体，此前该机构因上个月在没有证据证明对该疾病有明显益处的情况下批准该药物而招致尖锐批评。</blockquote></p><p> Shares of the company fell nearly 3% before the bell on Thursday.</p><p><blockquote>该公司股价周四盘前下跌近3%。</blockquote></p><p> The U.S. Food and Drug Administration has been criticized for its decision to allow wide use of Biogen’s Aduhelm among patients even though the company had tested the drug only in patients with early disease who tested positive for a component of amyloid brain plaques.</p><p><blockquote>美国。美国食品和药物管理局因决定允许Biogen的Aduhelm在患者中广泛使用而受到批评，尽管该公司仅在淀粉样脑斑块成分检测呈阳性的早期疾病患者中测试了该药物。</blockquote></p><p> Aduhelm, also known as aducanumab, was approved despite a lack of clear evidence showing the drug worked and against the advice of an outside group of advisers.</p><p><blockquote>Aduhelm，也称为aducanumab，尽管缺乏明确的证据表明该药物有效，并且违背了外部顾问小组的建议，但仍获得批准。</blockquote></p><p> Several members of the FDA’s advisory panel have resigned in protest over the approval.</p><p><blockquote>FDA顾问小组的几名成员已经辞职，以抗议批准。</blockquote></p><p> Biogen said it had asked for an update to the label, a written information that accompanies a drug, after “dialogue with FDA, physicians and patient advocates.” “The intent is to help prescribing physicians to engage with patients,” Biogen said in a statement.</p><p><blockquote>百健(Biogen)表示，在“与FDA、医生和患者权益倡导者对话”后，已要求更新标签（药物附带的书面信息）。百健(Biogen)在一份声明中表示：“其目的是帮助处方医生与患者互动。”</blockquote></p><p> The new label says that treatment with the drug should be initiated in patients with mild cognitive impairment or mild dementia stage of the disease.</p><p><blockquote>新标签称，轻度认知障碍或轻度痴呆阶段的患者应开始使用该药物进行治疗。</blockquote></p><p> It also says there is no safety or effectiveness data on initiating treatment at earlier or later stages of the disease.</p><p><blockquote>它还表示，没有关于在疾病早期或晚期开始治疗的安全性或有效性数据。</blockquote></p><p> The new patient population is largely in-line with how the drug was expected to be used, Truist Securities analyst Robyn Karnauskas said in a note. She expects roughly $12 billion in peak sales by 2031.</p><p><blockquote>Truist Securities分析师Robyn Karnauskas在一份报告中表示，新的患者群体在很大程度上符合该药物的预期使用方式。她预计到2031年销售额峰值约为120亿美元。</blockquote></p><p> Biogen’s drug has been hailed by patient advocates and some neurologists eager for a treatment for the memory-robbing disease. Other doctors said clinical trial results were inconsistent and more proof was needed.</p><p><blockquote>百健(Biogen)的药物受到了患者权益倡导者和一些渴望治疗这种记忆丧失疾病的神经科医生的欢迎。其他医生表示，临床试验结果不一致，需要更多证据。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. FDA narrows patient group for Biogen's Alzheimer's drug<blockquote>美国FDA缩小百健阿尔茨海默病药物患者群体范围</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. FDA narrows patient group for Biogen's Alzheimer's drug<blockquote>美国FDA缩小百健阿尔茨海默病药物患者群体范围</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-07-08 21:21</span>\n</p>\n</h4>\n</header>\n<article>\n<p>July 8 (Reuters) - Biogen Inc said the U.S. drug regulator has narrowed the patient group that can use its Alzheimer’s disease drug, after the agency drew sharp criticism for approving the drug last month without proof of clear benefit against the disease.</p><p><blockquote>路透7月8日-百健公司(Biogen Inc)表示，美国药品监管机构已缩小了可以使用其阿尔茨海默病药物的患者群体，此前该机构因上个月在没有证据证明对该疾病有明显益处的情况下批准该药物而招致尖锐批评。</blockquote></p><p> Shares of the company fell nearly 3% before the bell on Thursday.</p><p><blockquote>该公司股价周四盘前下跌近3%。</blockquote></p><p> The U.S. Food and Drug Administration has been criticized for its decision to allow wide use of Biogen’s Aduhelm among patients even though the company had tested the drug only in patients with early disease who tested positive for a component of amyloid brain plaques.</p><p><blockquote>美国。美国食品和药物管理局因决定允许Biogen的Aduhelm在患者中广泛使用而受到批评，尽管该公司仅在淀粉样脑斑块成分检测呈阳性的早期疾病患者中测试了该药物。</blockquote></p><p> Aduhelm, also known as aducanumab, was approved despite a lack of clear evidence showing the drug worked and against the advice of an outside group of advisers.</p><p><blockquote>Aduhelm，也称为aducanumab，尽管缺乏明确的证据表明该药物有效，并且违背了外部顾问小组的建议，但仍获得批准。</blockquote></p><p> Several members of the FDA’s advisory panel have resigned in protest over the approval.</p><p><blockquote>FDA顾问小组的几名成员已经辞职，以抗议批准。</blockquote></p><p> Biogen said it had asked for an update to the label, a written information that accompanies a drug, after “dialogue with FDA, physicians and patient advocates.” “The intent is to help prescribing physicians to engage with patients,” Biogen said in a statement.</p><p><blockquote>百健(Biogen)表示，在“与FDA、医生和患者权益倡导者对话”后，已要求更新标签（药物附带的书面信息）。百健(Biogen)在一份声明中表示：“其目的是帮助处方医生与患者互动。”</blockquote></p><p> The new label says that treatment with the drug should be initiated in patients with mild cognitive impairment or mild dementia stage of the disease.</p><p><blockquote>新标签称，轻度认知障碍或轻度痴呆阶段的患者应开始使用该药物进行治疗。</blockquote></p><p> It also says there is no safety or effectiveness data on initiating treatment at earlier or later stages of the disease.</p><p><blockquote>它还表示，没有关于在疾病早期或晚期开始治疗的安全性或有效性数据。</blockquote></p><p> The new patient population is largely in-line with how the drug was expected to be used, Truist Securities analyst Robyn Karnauskas said in a note. She expects roughly $12 billion in peak sales by 2031.</p><p><blockquote>Truist Securities分析师Robyn Karnauskas在一份报告中表示，新的患者群体在很大程度上符合该药物的预期使用方式。她预计到2031年销售额峰值约为120亿美元。</blockquote></p><p> Biogen’s drug has been hailed by patient advocates and some neurologists eager for a treatment for the memory-robbing disease. Other doctors said clinical trial results were inconsistent and more proof was needed.</p><p><blockquote>百健(Biogen)的药物受到了患者权益倡导者和一些渴望治疗这种记忆丧失疾病的神经科医生的欢迎。其他医生表示，临床试验结果不一致，需要更多证据。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.reuters.com/article/biogen-alzheimers-fda/update-2-u-s-fda-narrows-patient-group-for-biogens-alzheimers-drug-idUSL3N2OK2XT\">Reuters</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.reuters.com/article/biogen-alzheimers-fda/update-2-u-s-fda-narrows-patient-group-for-biogens-alzheimers-drug-idUSL3N2OK2XT","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1184325113","content_text":"July 8 (Reuters) - Biogen Inc said the U.S. drug regulator has narrowed the patient group that can use its Alzheimer’s disease drug, after the agency drew sharp criticism for approving the drug last month without proof of clear benefit against the disease.\nShares of the company fell nearly 3% before the bell on Thursday.\nThe U.S. Food and Drug Administration has been criticized for its decision to allow wide use of Biogen’s Aduhelm among patients even though the company had tested the drug only in patients with early disease who tested positive for a component of amyloid brain plaques.\nAduhelm, also known as aducanumab, was approved despite a lack of clear evidence showing the drug worked and against the advice of an outside group of advisers.\nSeveral members of the FDA’s advisory panel have resigned in protest over the approval.\nBiogen said it had asked for an update to the label, a written information that accompanies a drug, after “dialogue with FDA, physicians and patient advocates.” “The intent is to help prescribing physicians to engage with patients,” Biogen said in a statement.\nThe new label says that treatment with the drug should be initiated in patients with mild cognitive impairment or mild dementia stage of the disease.\nIt also says there is no safety or effectiveness data on initiating treatment at earlier or later stages of the disease.\nThe new patient population is largely in-line with how the drug was expected to be used, Truist Securities analyst Robyn Karnauskas said in a note. She expects roughly $12 billion in peak sales by 2031.\nBiogen’s drug has been hailed by patient advocates and some neurologists eager for a treatment for the memory-robbing disease. Other doctors said clinical trial results were inconsistent and more proof was needed.","news_type":1,"symbols_score_info":{"BIIB":0.9}},"isVote":1,"tweetType":1,"viewCount":2011,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":157264925,"gmtCreate":1625584172867,"gmtModify":1631884986880,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577341055310022","authorIdStr":"3577341055310022"},"themes":[],"title":"","htmlText":"No","listText":"No","text":"No","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/157264925","repostId":"1122401659","repostType":4,"isVote":1,"tweetType":1,"viewCount":2738,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":157262209,"gmtCreate":1625584128801,"gmtModify":1631884986890,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577341055310022","authorIdStr":"3577341055310022"},"themes":[],"title":"","htmlText":"No.no.no","listText":"No.no.no","text":"No.no.no","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/157262209","repostId":"1150315172","repostType":4,"isVote":1,"tweetType":1,"viewCount":2774,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":152614613,"gmtCreate":1625287271232,"gmtModify":1631884986900,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577341055310022","authorIdStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/152614613","repostId":"1140994998","repostType":4,"isVote":1,"tweetType":1,"viewCount":2261,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":124008630,"gmtCreate":1624702194220,"gmtModify":1631884986913,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577341055310022","authorIdStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/124008630","repostId":"2146008543","repostType":4,"isVote":1,"tweetType":1,"viewCount":2322,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":184553760,"gmtCreate":1623719573950,"gmtModify":1631884986924,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577341055310022","authorIdStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Agreed 👍","listText":"Agreed 👍","text":"Agreed 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/184553760","repostId":"2143178756","repostType":4,"isVote":1,"tweetType":1,"viewCount":2482,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182881408,"gmtCreate":1623562731504,"gmtModify":1634031633499,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577341055310022","authorIdStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good//<a href=\"https://laohu8.com/U/3570755698252810\">@螞蟻東尼</a>: 這篇文章不錯，轉發給大家看看","listText":"Good//<a href=\"https://laohu8.com/U/3570755698252810\">@螞蟻東尼</a>: 這篇文章不錯，轉發給大家看看","text":"Good//@螞蟻東尼: 這篇文章不錯，轉發給大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/182881408","repostId":"181297335","repostType":1,"repost":{"id":181297335,"gmtCreate":1623395075523,"gmtModify":1623434242396,"author":{"id":"3468322318173915","authorId":"3468322318173915","name":"阳光财经","avatar":"https://static.tigerbbs.com/ae4ab676f150a8d357cb5f3e4956d1a0","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3468322318173915","authorIdStr":"3468322318173915"},"themes":[],"title":"","htmlText":"\n \n \n  美股分析：这么一大利空，标普创新高无果。\n \n","listText":"美股分析：这么一大利空，标普创新高无果。","text":"美股分析：这么一大利空，标普创新高无果。","images":[],"top":1,"highlighted":2,"essential":2,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/181297335","isVote":1,"tweetType":2,"object":{"id":"4174a0e07fd04f3098232a70d1dd45ea","tweetId":"181297335","title":"美股分析：这么一大利空，标普创新高无果。","videoUrl":"http://v.tigerbbs.com/1623395070474792f422fd34b3bb27bec3468d08fc440.mp4","poster":"https://static.tigerbbs.com/1ee8b26d625d5af0cd80aa1c4bebbec2","shareLink":"http://v.tigerbbs.com/1623395070474792f422fd34b3bb27bec3468d08fc440.mp4"},"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1178,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":182881100,"gmtCreate":1623562698800,"gmtModify":1634031633968,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577341055310022","authorIdStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/182881100","repostId":"2143788707","repostType":4,"isVote":1,"tweetType":1,"viewCount":955,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":188444184,"gmtCreate":1623460391448,"gmtModify":1634032942475,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577341055310022","authorIdStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/188444184","repostId":"2142025622","repostType":4,"isVote":1,"tweetType":1,"viewCount":750,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":189475315,"gmtCreate":1623287205237,"gmtModify":1634034970994,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577341055310022","authorIdStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Haiz&nbsp;","listText":"Haiz&nbsp;","text":"Haiz","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/189475315","repostId":"1114317619","repostType":4,"isVote":1,"tweetType":1,"viewCount":953,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":180448661,"gmtCreate":1623223279953,"gmtModify":1634035636941,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577341055310022","authorIdStr":"3577341055310022"},"themes":[],"title":"","htmlText":"It Is game over","listText":"It Is game over","text":"It Is game over","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/180448661","repostId":"1158084619","repostType":4,"isVote":1,"tweetType":1,"viewCount":919,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":116022736,"gmtCreate":1622766990325,"gmtModify":1634098269303,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577341055310022","authorIdStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Unbelievable&nbsp;","listText":"Unbelievable&nbsp;","text":"Unbelievable","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/116022736","repostId":"1182776229","repostType":4,"isVote":1,"tweetType":1,"viewCount":910,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":118027850,"gmtCreate":1622709065270,"gmtModify":1634098921739,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577341055310022","authorIdStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/118027850","repostId":"2140705444","repostType":4,"isVote":1,"tweetType":1,"viewCount":843,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":118025774,"gmtCreate":1622709012898,"gmtModify":1634098922670,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577341055310022","authorIdStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/118025774","repostId":"1177656700","repostType":4,"isVote":1,"tweetType":1,"viewCount":794,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":111051293,"gmtCreate":1622645660512,"gmtModify":1634099605722,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577341055310022","authorIdStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good&nbsp;&nbsp;","listText":"Good&nbsp;&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/111051293","repostId":"1169651707","repostType":4,"isVote":1,"tweetType":1,"viewCount":826,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":119980435,"gmtCreate":1622513195027,"gmtModify":1634100937262,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577341055310022","authorIdStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good move","listText":"Good move","text":"Good move","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/119980435","repostId":"1198461252","repostType":2,"isVote":1,"tweetType":1,"viewCount":823,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":110338041,"gmtCreate":1622424890383,"gmtModify":1634101621537,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Omg","listText":"Omg","text":"Omg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/110338041","repostId":"2139487366","repostType":2,"repost":{"id":"2139487366","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1622359710,"share":"https://www.laohu8.com/m/news/2139487366?lang=zh_CN&edition=full","pubTime":"2021-05-30 15:28","language":"en","title":"NASDAQ TRADE HALT CONTINUES    REASON NOT AVAILABLE AT 03:28 AM<blockquote>纳斯达克交易继续暂停，凌晨03:28原因不可用</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2139487366","media":"Reuters","summary":"NASDAQ TRADE HALT CONTINUES    REASON NOT AVAILABLE AT 03:28 AM","content":"<p><html><body>NASDAQ TRADE HALT CONTINUES    REASON NOT AVAILABLE AT 03:28 AM</p><p><blockquote><html><body>纳斯达克交易继续暂停，凌晨03:28原因不可用</body></html></blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NASDAQ TRADE HALT CONTINUES    REASON NOT AVAILABLE AT 03:28 AM<blockquote>纳斯达克交易继续暂停，凌晨03:28原因不可用</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNASDAQ TRADE HALT CONTINUES    REASON NOT AVAILABLE AT 03:28 AM<blockquote>纳斯达克交易继续暂停，凌晨03:28原因不可用</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2021-05-30 15:28</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><html><body>NASDAQ TRADE HALT CONTINUES    REASON NOT AVAILABLE AT 03:28 AM</p><p><blockquote><html><body>纳斯达克交易继续暂停，凌晨03:28原因不可用</body></html></blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QID":"两倍做空纳斯达克指数ETF-ProShares","QLD":"2倍做多纳斯达克100指数ETF-ProShares",".IXIC":"NASDAQ Composite","QQQ":"纳指100ETF","PSQ":"做空纳斯达克100指数ETF-ProShares","TQQQ":"纳指三倍做多ETF","IMC.AU":"IMMURON LTD","SQQQ":"纳指三倍做空ETF","NDAQ":"纳斯达克OMX交易所"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2139487366","content_text":"NASDAQ TRADE HALT CONTINUES    REASON NOT AVAILABLE AT 03:28 AM","news_type":1,"symbols_score_info":{"MNQmain":0.6,"PSQ":0.6,"SQQQ":0.6,"IMC.AU":0.9,"QLD":0.6,"NDAQ":1,"TQQQ":0.6,"NQmain":0.6,".IXIC":1,"QID":0.6,"QQQ":0.6}},"isVote":1,"tweetType":1,"viewCount":824,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":138421328,"gmtCreate":1621955130864,"gmtModify":1634185157902,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Yes&nbsp;","listText":"Yes&nbsp;","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/138421328","repostId":"2138193568","repostType":2,"isVote":1,"tweetType":1,"viewCount":645,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":184553760,"gmtCreate":1623719573950,"gmtModify":1631884986924,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Agreed 👍","listText":"Agreed 👍","text":"Agreed 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/184553760","repostId":"2143178756","repostType":4,"isVote":1,"tweetType":1,"viewCount":2482,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":189475315,"gmtCreate":1623287205237,"gmtModify":1634034970994,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Haiz&nbsp;","listText":"Haiz&nbsp;","text":"Haiz","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/189475315","repostId":"1114317619","repostType":4,"isVote":1,"tweetType":1,"viewCount":953,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":194661884,"gmtCreate":1621378393248,"gmtModify":1634192110798,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Wow&nbsp;","listText":"Wow&nbsp;","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/194661884","repostId":"2135161248","repostType":4,"repost":{"id":"2135161248","kind":"news","pubTimestamp":1621343169,"share":"https://www.laohu8.com/m/news/2135161248?lang=zh_CN&edition=full","pubTime":"2021-05-18 21:06","market":"us","language":"en","title":"JD.com to Report Q1 Earnings: What's in the Cards?<blockquote>京东将报告第一季度收益：前景如何？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2135161248","media":"Zacks","summary":"JD.com, Inc. is scheduled to report first-quarter 2021 results on May 19.\nFor the first quarter, the","content":"<p><b>JD.com, Inc.</b>&nbsp;is scheduled to report first-quarter 2021 results on May 19.</p><p><blockquote><b>京东公司。</b>计划于5月19日公布2021年第一季度业绩。</blockquote></p><p> For the first quarter, the Zacks Consensus Estimate for revenues is pegged at $29.9 billion, indicating an improvement of 44.9% from the year-ago reported figure.</p><p><blockquote>对于第一季度，Zacks对收入的一致预期为299亿美元，比去年同期报告的数字提高了44.9%。</blockquote></p><p> Further, the consensus mark for earnings is pegged at 39 cents per share, indicating a 39.3% rise from the previous-year reported figure.</p><p><blockquote>此外，普遍预期的盈利为每股39美分，比上一年报告的数字增长39.3%。</blockquote></p><p> Notably, the company delivered an earnings surprise of 4.6% in the last reported quarter.</p><p><blockquote>值得注意的是，该公司在上一季度的盈利意外增长了4.6%。</blockquote></p><p> <b>JD.com, Inc. Price and EPS Surprise</b></p><p><blockquote><b>京东公司。价格和每股收益惊喜</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c1fed1c36f6a8ce20878c0d2e594f77c\" tg-width=\"534\" tg-height=\"262\"><span>JD.com, Inc. price-eps-surprise | JD.com, Inc. Quote</span></p><p><blockquote><p class=\"t-img-caption\"><span>京东公司价格-每股收益-惊喜|京东公司报价</span></p></blockquote></p><p> <b>Key Factors to Note</b></p><p><blockquote><b>需要注意的关键因素</b></blockquote></p><p> The company’s JD Retail segment, comprising the e-commerce business, is expected to have been the key catalyst in the first quarter.</p><p><blockquote>该公司的京东零售部门（包括电子商务业务）预计将成为第一季度的关键催化剂。</blockquote></p><p> The launch of flagship stores of popular fashion and luxury brands like John Lobb, Stefano Ricci, Vivienne Westwoodon and Anya Hindmarch, among others, on JD.com is likely to have driven customer momentum, which in turn is expected to have aided the performance of JD Retail during the quarter-to-be-reported.</p><p><blockquote>John Lobb、Stefano Ricci、Vivienne Westwoodon和Anya Hindmarch等流行时尚和奢侈品牌在京东上开设旗舰店可能会推动客户势头，预计这反过来将有助于京东零售在待报告季度的表现。</blockquote></p><p> JD retail’s omni-channel initiatives are anticipated to have contributed well to top-line growth of the segment in the first quarter.</p><p><blockquote>京东零售的全渠道举措预计将为该细分市场第一季度的营收增长做出良好贡献。</blockquote></p><p> Moreover, the company’s collaboration with Italian luxury brands Prada and MiuMiu, which bolstered its omni-channel efforts, might have been a positive.</p><p><blockquote>此外，该公司与意大利奢侈品牌Prada和MiuMiu的合作可能是积极的，这加强了其全渠道努力。</blockquote></p><p> Furthermore, growing momentum of JD health that offers free online medical consultation and online pharmacy retail services is likely to get reflected in the company’s to-be-reported quarter’s results.</p><p><blockquote>此外，京东健康提供免费在线医疗咨询和在线药店零售服务的增长势头可能会反映在该公司即将报告的季度业绩中。</blockquote></p><p> Growing investments in research and development are also likely to have been encouraging for the company in the quarter under review.</p><p><blockquote>在本季度，不断增长的研发投资也可能对该公司来说令人鼓舞。</blockquote></p><p> Additionally, the new businesses segment comprising technology, supply chain and logistics services is expected to have helped it in gaining traction across lower-tier cities in the first quarter.</p><p><blockquote>此外，由技术、供应链和物流服务组成的新业务部门预计将帮助其在第一季度在低线城市获得牵引力。</blockquote></p><p> Moreover, the well-performing Jingxi Business Group is expected to have aided JD.com’s performance in the lower-tier cities.</p><p><blockquote>此外，表现良好的京西业务集团预计将有助于京东在低线城市的表现。</blockquote></p><p> However, increasing fulfilment, marketing, and research and development expenses are likely to have been major risks to the company’s profitability in the quarter under review.</p><p><blockquote>然而，履行、营销和研发费用的增加可能是公司本季度盈利能力的主要风险。</blockquote></p><p> Moreover, increasing competitive pressure from Alibaba in the e-commerce market might be reflected in first-quarter results.</p><p><blockquote>此外，阿里巴巴-SW在电子商务市场日益增长的竞争压力可能会反映在第一季度的业绩中。</blockquote></p><p> <b>What Our Model Says</b></p><p><blockquote><b>我们的模型所说的</b></blockquote></p><p> Our proven model does not conclusively predict an earnings beat for JD.com this time around. The combination of a positiveEarnings ESPand a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with ourEarnings ESP Filter.</p><p><blockquote>我们经过验证的模型并没有最终预测京东这次的盈利会超出预期。正收益ESP和咤克斯排名#1（强力买入）、2（买入）或3（持有）的组合增加了收益超出预期的可能性。但这里的情况并非如此。您可以在使用我们的收益ESP过滤器报告之前发现最值得买入或卖出的股票。</blockquote></p><p> JD.com has an Earnings ESP of -14.83% and a Zacks Rank #5 (Strong Sell), at present.</p><p><blockquote>目前，京东的收益ESP为-14.83%，咤克斯排名第五（强力卖出）。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JD.com to Report Q1 Earnings: What's in the Cards?<blockquote>京东将报告第一季度收益：前景如何？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJD.com to Report Q1 Earnings: What's in the Cards?<blockquote>京东将报告第一季度收益：前景如何？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Zacks</strong><span class=\"h-time small\">2021-05-18 21:06</span>\n</p>\n</h4>\n</header>\n<article>\n<p><b>JD.com, Inc.</b>&nbsp;is scheduled to report first-quarter 2021 results on May 19.</p><p><blockquote><b>京东公司。</b>计划于5月19日公布2021年第一季度业绩。</blockquote></p><p> For the first quarter, the Zacks Consensus Estimate for revenues is pegged at $29.9 billion, indicating an improvement of 44.9% from the year-ago reported figure.</p><p><blockquote>对于第一季度，Zacks对收入的一致预期为299亿美元，比去年同期报告的数字提高了44.9%。</blockquote></p><p> Further, the consensus mark for earnings is pegged at 39 cents per share, indicating a 39.3% rise from the previous-year reported figure.</p><p><blockquote>此外，普遍预期的盈利为每股39美分，比上一年报告的数字增长39.3%。</blockquote></p><p> Notably, the company delivered an earnings surprise of 4.6% in the last reported quarter.</p><p><blockquote>值得注意的是，该公司在上一季度的盈利意外增长了4.6%。</blockquote></p><p> <b>JD.com, Inc. Price and EPS Surprise</b></p><p><blockquote><b>京东公司。价格和每股收益惊喜</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c1fed1c36f6a8ce20878c0d2e594f77c\" tg-width=\"534\" tg-height=\"262\"><span>JD.com, Inc. price-eps-surprise | JD.com, Inc. Quote</span></p><p><blockquote><p class=\"t-img-caption\"><span>京东公司价格-每股收益-惊喜|京东公司报价</span></p></blockquote></p><p> <b>Key Factors to Note</b></p><p><blockquote><b>需要注意的关键因素</b></blockquote></p><p> The company’s JD Retail segment, comprising the e-commerce business, is expected to have been the key catalyst in the first quarter.</p><p><blockquote>该公司的京东零售部门（包括电子商务业务）预计将成为第一季度的关键催化剂。</blockquote></p><p> The launch of flagship stores of popular fashion and luxury brands like John Lobb, Stefano Ricci, Vivienne Westwoodon and Anya Hindmarch, among others, on JD.com is likely to have driven customer momentum, which in turn is expected to have aided the performance of JD Retail during the quarter-to-be-reported.</p><p><blockquote>John Lobb、Stefano Ricci、Vivienne Westwoodon和Anya Hindmarch等流行时尚和奢侈品牌在京东上开设旗舰店可能会推动客户势头，预计这反过来将有助于京东零售在待报告季度的表现。</blockquote></p><p> JD retail’s omni-channel initiatives are anticipated to have contributed well to top-line growth of the segment in the first quarter.</p><p><blockquote>京东零售的全渠道举措预计将为该细分市场第一季度的营收增长做出良好贡献。</blockquote></p><p> Moreover, the company’s collaboration with Italian luxury brands Prada and MiuMiu, which bolstered its omni-channel efforts, might have been a positive.</p><p><blockquote>此外，该公司与意大利奢侈品牌Prada和MiuMiu的合作可能是积极的，这加强了其全渠道努力。</blockquote></p><p> Furthermore, growing momentum of JD health that offers free online medical consultation and online pharmacy retail services is likely to get reflected in the company’s to-be-reported quarter’s results.</p><p><blockquote>此外，京东健康提供免费在线医疗咨询和在线药店零售服务的增长势头可能会反映在该公司即将报告的季度业绩中。</blockquote></p><p> Growing investments in research and development are also likely to have been encouraging for the company in the quarter under review.</p><p><blockquote>在本季度，不断增长的研发投资也可能对该公司来说令人鼓舞。</blockquote></p><p> Additionally, the new businesses segment comprising technology, supply chain and logistics services is expected to have helped it in gaining traction across lower-tier cities in the first quarter.</p><p><blockquote>此外，由技术、供应链和物流服务组成的新业务部门预计将帮助其在第一季度在低线城市获得牵引力。</blockquote></p><p> Moreover, the well-performing Jingxi Business Group is expected to have aided JD.com’s performance in the lower-tier cities.</p><p><blockquote>此外，表现良好的京西业务集团预计将有助于京东在低线城市的表现。</blockquote></p><p> However, increasing fulfilment, marketing, and research and development expenses are likely to have been major risks to the company’s profitability in the quarter under review.</p><p><blockquote>然而，履行、营销和研发费用的增加可能是公司本季度盈利能力的主要风险。</blockquote></p><p> Moreover, increasing competitive pressure from Alibaba in the e-commerce market might be reflected in first-quarter results.</p><p><blockquote>此外，阿里巴巴-SW在电子商务市场日益增长的竞争压力可能会反映在第一季度的业绩中。</blockquote></p><p> <b>What Our Model Says</b></p><p><blockquote><b>我们的模型所说的</b></blockquote></p><p> Our proven model does not conclusively predict an earnings beat for JD.com this time around. The combination of a positiveEarnings ESPand a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with ourEarnings ESP Filter.</p><p><blockquote>我们经过验证的模型并没有最终预测京东这次的盈利会超出预期。正收益ESP和咤克斯排名#1（强力买入）、2（买入）或3（持有）的组合增加了收益超出预期的可能性。但这里的情况并非如此。您可以在使用我们的收益ESP过滤器报告之前发现最值得买入或卖出的股票。</blockquote></p><p> JD.com has an Earnings ESP of -14.83% and a Zacks Rank #5 (Strong Sell), at present.</p><p><blockquote>目前，京东的收益ESP为-14.83%，咤克斯排名第五（强力卖出）。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.zacks.com/stock/news/1541348/jdcom-jd-to-report-q1-earnings-whats-in-the-cards?art_rec=quote-stock_overview-zacks_news-ID02-txt-1541348\">Zacks</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JD":"京东","09618":"京东集团-SW"},"source_url":"https://www.zacks.com/stock/news/1541348/jdcom-jd-to-report-q1-earnings-whats-in-the-cards?art_rec=quote-stock_overview-zacks_news-ID02-txt-1541348","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2135161248","content_text":"JD.com, Inc. is scheduled to report first-quarter 2021 results on May 19.\nFor the first quarter, the Zacks Consensus Estimate for revenues is pegged at $29.9 billion, indicating an improvement of 44.9% from the year-ago reported figure.\nFurther, the consensus mark for earnings is pegged at 39 cents per share, indicating a 39.3% rise from the previous-year reported figure.\nNotably, the company delivered an earnings surprise of 4.6% in the last reported quarter.\nJD.com, Inc. Price and EPS Surprise\nJD.com, Inc. price-eps-surprise | JD.com, Inc. Quote\nKey Factors to Note\nThe company’s JD Retail segment, comprising the e-commerce business, is expected to have been the key catalyst in the first quarter.\nThe launch of flagship stores of popular fashion and luxury brands like John Lobb, Stefano Ricci, Vivienne Westwoodon and Anya Hindmarch, among others, on JD.com is likely to have driven customer momentum, which in turn is expected to have aided the performance of JD Retail during the quarter-to-be-reported.\nJD retail’s omni-channel initiatives are anticipated to have contributed well to top-line growth of the segment in the first quarter.\nMoreover, the company’s collaboration with Italian luxury brands Prada and MiuMiu, which bolstered its omni-channel efforts, might have been a positive.\nFurthermore, growing momentum of JD health that offers free online medical consultation and online pharmacy retail services is likely to get reflected in the company’s to-be-reported quarter’s results.\nGrowing investments in research and development are also likely to have been encouraging for the company in the quarter under review.\nAdditionally, the new businesses segment comprising technology, supply chain and logistics services is expected to have helped it in gaining traction across lower-tier cities in the first quarter.\nMoreover, the well-performing Jingxi Business Group is expected to have aided JD.com’s performance in the lower-tier cities.\nHowever, increasing fulfilment, marketing, and research and development expenses are likely to have been major risks to the company’s profitability in the quarter under review.\nMoreover, increasing competitive pressure from Alibaba in the e-commerce market might be reflected in first-quarter results.\nWhat Our Model Says\nOur proven model does not conclusively predict an earnings beat for JD.com this time around. The combination of a positiveEarnings ESPand a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with ourEarnings ESP Filter.\nJD.com has an Earnings ESP of -14.83% and a Zacks Rank #5 (Strong Sell), at present.","news_type":1,"symbols_score_info":{"09618":0.9,"JD":0.9}},"isVote":1,"tweetType":1,"viewCount":678,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":157264925,"gmtCreate":1625584172867,"gmtModify":1631884986880,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"No","listText":"No","text":"No","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/157264925","repostId":"1122401659","repostType":4,"isVote":1,"tweetType":1,"viewCount":2738,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182881100,"gmtCreate":1623562698800,"gmtModify":1634031633968,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/182881100","repostId":"2143788707","repostType":4,"isVote":1,"tweetType":1,"viewCount":955,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":111051293,"gmtCreate":1622645660512,"gmtModify":1634099605722,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good&nbsp;&nbsp;","listText":"Good&nbsp;&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/111051293","repostId":"1169651707","repostType":4,"isVote":1,"tweetType":1,"viewCount":826,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":170737981,"gmtCreate":1626450507243,"gmtModify":1631884986830,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/170737981","repostId":"1179740731","repostType":4,"isVote":1,"tweetType":1,"viewCount":2396,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":143092981,"gmtCreate":1625751825943,"gmtModify":1631884986868,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/143092981","repostId":"1184325113","repostType":4,"repost":{"id":"1184325113","kind":"news","pubTimestamp":1625750497,"share":"https://www.laohu8.com/m/news/1184325113?lang=zh_CN&edition=full","pubTime":"2021-07-08 21:21","market":"us","language":"en","title":"U.S. FDA narrows patient group for Biogen's Alzheimer's drug<blockquote>美国FDA缩小百健阿尔茨海默病药物患者群体范围</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1184325113","media":"Reuters","summary":"July 8 (Reuters) - Biogen Inc said the U.S. drug regulator has narrowed the patient group that can u","content":"<p>July 8 (Reuters) - Biogen Inc said the U.S. drug regulator has narrowed the patient group that can use its Alzheimer’s disease drug, after the agency drew sharp criticism for approving the drug last month without proof of clear benefit against the disease.</p><p><blockquote>路透7月8日-百健公司(Biogen Inc)表示，美国药品监管机构已缩小了可以使用其阿尔茨海默病药物的患者群体，此前该机构因上个月在没有证据证明对该疾病有明显益处的情况下批准该药物而招致尖锐批评。</blockquote></p><p> Shares of the company fell nearly 3% before the bell on Thursday.</p><p><blockquote>该公司股价周四盘前下跌近3%。</blockquote></p><p> The U.S. Food and Drug Administration has been criticized for its decision to allow wide use of Biogen’s Aduhelm among patients even though the company had tested the drug only in patients with early disease who tested positive for a component of amyloid brain plaques.</p><p><blockquote>美国。美国食品和药物管理局因决定允许Biogen的Aduhelm在患者中广泛使用而受到批评，尽管该公司仅在淀粉样脑斑块成分检测呈阳性的早期疾病患者中测试了该药物。</blockquote></p><p> Aduhelm, also known as aducanumab, was approved despite a lack of clear evidence showing the drug worked and against the advice of an outside group of advisers.</p><p><blockquote>Aduhelm，也称为aducanumab，尽管缺乏明确的证据表明该药物有效，并且违背了外部顾问小组的建议，但仍获得批准。</blockquote></p><p> Several members of the FDA’s advisory panel have resigned in protest over the approval.</p><p><blockquote>FDA顾问小组的几名成员已经辞职，以抗议批准。</blockquote></p><p> Biogen said it had asked for an update to the label, a written information that accompanies a drug, after “dialogue with FDA, physicians and patient advocates.” “The intent is to help prescribing physicians to engage with patients,” Biogen said in a statement.</p><p><blockquote>百健(Biogen)表示，在“与FDA、医生和患者权益倡导者对话”后，已要求更新标签（药物附带的书面信息）。百健(Biogen)在一份声明中表示：“其目的是帮助处方医生与患者互动。”</blockquote></p><p> The new label says that treatment with the drug should be initiated in patients with mild cognitive impairment or mild dementia stage of the disease.</p><p><blockquote>新标签称，轻度认知障碍或轻度痴呆阶段的患者应开始使用该药物进行治疗。</blockquote></p><p> It also says there is no safety or effectiveness data on initiating treatment at earlier or later stages of the disease.</p><p><blockquote>它还表示，没有关于在疾病早期或晚期开始治疗的安全性或有效性数据。</blockquote></p><p> The new patient population is largely in-line with how the drug was expected to be used, Truist Securities analyst Robyn Karnauskas said in a note. She expects roughly $12 billion in peak sales by 2031.</p><p><blockquote>Truist Securities分析师Robyn Karnauskas在一份报告中表示，新的患者群体在很大程度上符合该药物的预期使用方式。她预计到2031年销售额峰值约为120亿美元。</blockquote></p><p> Biogen’s drug has been hailed by patient advocates and some neurologists eager for a treatment for the memory-robbing disease. Other doctors said clinical trial results were inconsistent and more proof was needed.</p><p><blockquote>百健(Biogen)的药物受到了患者权益倡导者和一些渴望治疗这种记忆丧失疾病的神经科医生的欢迎。其他医生表示，临床试验结果不一致，需要更多证据。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. FDA narrows patient group for Biogen's Alzheimer's drug<blockquote>美国FDA缩小百健阿尔茨海默病药物患者群体范围</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. FDA narrows patient group for Biogen's Alzheimer's drug<blockquote>美国FDA缩小百健阿尔茨海默病药物患者群体范围</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-07-08 21:21</span>\n</p>\n</h4>\n</header>\n<article>\n<p>July 8 (Reuters) - Biogen Inc said the U.S. drug regulator has narrowed the patient group that can use its Alzheimer’s disease drug, after the agency drew sharp criticism for approving the drug last month without proof of clear benefit against the disease.</p><p><blockquote>路透7月8日-百健公司(Biogen Inc)表示，美国药品监管机构已缩小了可以使用其阿尔茨海默病药物的患者群体，此前该机构因上个月在没有证据证明对该疾病有明显益处的情况下批准该药物而招致尖锐批评。</blockquote></p><p> Shares of the company fell nearly 3% before the bell on Thursday.</p><p><blockquote>该公司股价周四盘前下跌近3%。</blockquote></p><p> The U.S. Food and Drug Administration has been criticized for its decision to allow wide use of Biogen’s Aduhelm among patients even though the company had tested the drug only in patients with early disease who tested positive for a component of amyloid brain plaques.</p><p><blockquote>美国。美国食品和药物管理局因决定允许Biogen的Aduhelm在患者中广泛使用而受到批评，尽管该公司仅在淀粉样脑斑块成分检测呈阳性的早期疾病患者中测试了该药物。</blockquote></p><p> Aduhelm, also known as aducanumab, was approved despite a lack of clear evidence showing the drug worked and against the advice of an outside group of advisers.</p><p><blockquote>Aduhelm，也称为aducanumab，尽管缺乏明确的证据表明该药物有效，并且违背了外部顾问小组的建议，但仍获得批准。</blockquote></p><p> Several members of the FDA’s advisory panel have resigned in protest over the approval.</p><p><blockquote>FDA顾问小组的几名成员已经辞职，以抗议批准。</blockquote></p><p> Biogen said it had asked for an update to the label, a written information that accompanies a drug, after “dialogue with FDA, physicians and patient advocates.” “The intent is to help prescribing physicians to engage with patients,” Biogen said in a statement.</p><p><blockquote>百健(Biogen)表示，在“与FDA、医生和患者权益倡导者对话”后，已要求更新标签（药物附带的书面信息）。百健(Biogen)在一份声明中表示：“其目的是帮助处方医生与患者互动。”</blockquote></p><p> The new label says that treatment with the drug should be initiated in patients with mild cognitive impairment or mild dementia stage of the disease.</p><p><blockquote>新标签称，轻度认知障碍或轻度痴呆阶段的患者应开始使用该药物进行治疗。</blockquote></p><p> It also says there is no safety or effectiveness data on initiating treatment at earlier or later stages of the disease.</p><p><blockquote>它还表示，没有关于在疾病早期或晚期开始治疗的安全性或有效性数据。</blockquote></p><p> The new patient population is largely in-line with how the drug was expected to be used, Truist Securities analyst Robyn Karnauskas said in a note. She expects roughly $12 billion in peak sales by 2031.</p><p><blockquote>Truist Securities分析师Robyn Karnauskas在一份报告中表示，新的患者群体在很大程度上符合该药物的预期使用方式。她预计到2031年销售额峰值约为120亿美元。</blockquote></p><p> Biogen’s drug has been hailed by patient advocates and some neurologists eager for a treatment for the memory-robbing disease. Other doctors said clinical trial results were inconsistent and more proof was needed.</p><p><blockquote>百健(Biogen)的药物受到了患者权益倡导者和一些渴望治疗这种记忆丧失疾病的神经科医生的欢迎。其他医生表示，临床试验结果不一致，需要更多证据。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.reuters.com/article/biogen-alzheimers-fda/update-2-u-s-fda-narrows-patient-group-for-biogens-alzheimers-drug-idUSL3N2OK2XT\">Reuters</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.reuters.com/article/biogen-alzheimers-fda/update-2-u-s-fda-narrows-patient-group-for-biogens-alzheimers-drug-idUSL3N2OK2XT","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1184325113","content_text":"July 8 (Reuters) - Biogen Inc said the U.S. drug regulator has narrowed the patient group that can use its Alzheimer’s disease drug, after the agency drew sharp criticism for approving the drug last month without proof of clear benefit against the disease.\nShares of the company fell nearly 3% before the bell on Thursday.\nThe U.S. Food and Drug Administration has been criticized for its decision to allow wide use of Biogen’s Aduhelm among patients even though the company had tested the drug only in patients with early disease who tested positive for a component of amyloid brain plaques.\nAduhelm, also known as aducanumab, was approved despite a lack of clear evidence showing the drug worked and against the advice of an outside group of advisers.\nSeveral members of the FDA’s advisory panel have resigned in protest over the approval.\nBiogen said it had asked for an update to the label, a written information that accompanies a drug, after “dialogue with FDA, physicians and patient advocates.” “The intent is to help prescribing physicians to engage with patients,” Biogen said in a statement.\nThe new label says that treatment with the drug should be initiated in patients with mild cognitive impairment or mild dementia stage of the disease.\nIt also says there is no safety or effectiveness data on initiating treatment at earlier or later stages of the disease.\nThe new patient population is largely in-line with how the drug was expected to be used, Truist Securities analyst Robyn Karnauskas said in a note. She expects roughly $12 billion in peak sales by 2031.\nBiogen’s drug has been hailed by patient advocates and some neurologists eager for a treatment for the memory-robbing disease. Other doctors said clinical trial results were inconsistent and more proof was needed.","news_type":1,"symbols_score_info":{"BIIB":0.9}},"isVote":1,"tweetType":1,"viewCount":2011,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}